AHA Coding Clinic® for HCPCS - 2013 Issue 3; For Your Information

New HCPCS codes for certain drugs and biologicals

The CMS has created two new HCPCS codes for the reporting of certain drugs and biologicals in the hospital outpatient setting. The new HCPCS codes listed below were effective for the reporting of services since July 1, 2013. HCPCSLong descriptorQ2050* Injection, Doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg Q2051** Injection, Zoledronic acid, not otherwise specified, 1 mg Doxorubicin is a drug utilized in cancer chemotherapy treatment and Zoledronic acid is utilized in the treatment of a variety of bone disorders. *HCPCS code Q2050 replaced HCPCS code J9002, Injection, Doxorubicin Hydrochloride, Liposomal, Doxil, 10 mg, as of July 1...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.